plecanatide CIC
Selected indexed studies
- American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation. (Gastroenterology, 2023) [PMID:37211380]
- Plecanatide: First Global Approval. (Drugs, 2017) [PMID:28255961]
- American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation. (Am J Gastroenterol, 2023) [PMID:37204227]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation. (2023) pubmed
- American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation. (2023) pubmed
- Plecanatide: First Global Approval. (2017) pubmed
- Chronic idiopathic constipation in adults: epidemiology, pathophysiology, diagnosis and clinical management. (2018) pubmed
- Plecanatide: a new guanylate cyclase agonist for the treatment of chronic idiopathic constipation. (2018) pubmed
- Plecanatide for the treatment of chronic idiopathic constipation in adult patients. (2019) pubmed
- Plecanatide for the treatment of constipation-predominant irritable bowel syndrome. (2020) pubmed
- Benefit-Risk Assessment of Plecanatide in the Treatment of Chronic Idiopathic Constipation. (2019) pubmed
- Efficacy and safety of plecanatide in treating constipation predominant irritable bowel syndrome. (2018) pubmed
- Plecanatide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: Post hoc analyses of placebo-controlled trials in adults with severe constipation. (2023) pubmed